162 related articles for article (PubMed ID: 28163087)
1. L-β-N-methylamino-l-alanine (BMAA) nitrosation generates a cytotoxic DNA damaging alkylating agent: An unexplored mechanism for neurodegenerative disease.
Potjewyd G; Day PJ; Shangula S; Margison GP; Povey AC
Neurotoxicology; 2017 Mar; 59():105-109. PubMed ID: 28163087
[TBL] [Abstract][Full Text] [Related]
2. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations.
Okle O; Stemmer K; Deschl U; Dietrich DR
Toxicol Sci; 2013 Jan; 131(1):217-24. PubMed ID: 23047912
[TBL] [Abstract][Full Text] [Related]
3. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
Brownson DM; Mabry TJ; Leslie SW
J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
[TBL] [Abstract][Full Text] [Related]
4. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
5. BMAA and Neurodegenerative Illness.
Cox PA; Kostrzewa RM; Guillemin GJ
Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
[TBL] [Abstract][Full Text] [Related]
6. Genotoxic effects of neurotoxin ß-N-methylamino-l-alanine in human peripheral blood cells.
Gerić M; Gajski G; Domijan AM; Garaj-Vrhovac V; Filipič M; Žegura B
Chemosphere; 2019 Jan; 214():623-632. PubMed ID: 30290362
[TBL] [Abstract][Full Text] [Related]
7. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
Banack SA; Caller TA; Stommel EW
Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
[TBL] [Abstract][Full Text] [Related]
8. Weak BMAA toxicity compares with that of the dietary supplement β-alanine.
Lee M; McGeer PL
Neurobiol Aging; 2012 Jul; 33(7):1440-7. PubMed ID: 21236519
[TBL] [Abstract][Full Text] [Related]
9. Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.
Porojan C; Mitrovic SM; Yeo DC; Furey A
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Oct; 33(10):1570-1586. PubMed ID: 27652898
[TBL] [Abstract][Full Text] [Related]
10. Equilibrium Dynamics of β-N-Methylamino-L-Alanine (BMAA) and Its Carbamate Adducts at Physiological Conditions.
Zimmerman D; Goto JJ; Krishnan VV
PLoS One; 2016; 11(8):e0160491. PubMed ID: 27513925
[TBL] [Abstract][Full Text] [Related]
11. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Combined Toxicity of BMAA and Its Isomers 2,4-DAB and AEG In Vitro Using Human Neuroblastoma Cells.
Main BJ; Rodgers KJ
Neurotox Res; 2018 Jan; 33(1):33-42. PubMed ID: 28634653
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons.
Weiss JH; Koh JY; Choi DW
Brain Res; 1989 Sep; 497(1):64-71. PubMed ID: 2551452
[TBL] [Abstract][Full Text] [Related]
14. The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats.
Engskog MK; Karlsson O; Haglöf J; Elmsjö A; Brittebo E; Arvidsson T; Pettersson C
Toxicology; 2013 Oct; 312():6-11. PubMed ID: 23886855
[TBL] [Abstract][Full Text] [Related]
15. Augmentation and ionic mechanism of effect of beta-N-methylamino-L-alanine in presence of bicarbonate on membrane potential of Retzius nerve cells of the leech Haemopis sanguisuga.
Lopicic S; Nedeljkov V; Cemerikic D
Comp Biochem Physiol A Mol Integr Physiol; 2009 Jul; 153(3):284-92. PubMed ID: 19272457
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
17. β-N-methylamino-L-alanine (BMAA) uptake by the animal model, Daphnia magna and subsequent oxidative stress.
Esterhuizen-Londt M; Wiegand C; Downing TG
Toxicon; 2015 Jun; 100():20-6. PubMed ID: 25841344
[TBL] [Abstract][Full Text] [Related]
18. How does the neurotoxin β-N-methylamino-L-alanine exist in biological matrices and cause toxicity?
Li M; Qiu J; Yan G; Zheng X; Li A
Sci Total Environ; 2024 Apr; 922():171255. PubMed ID: 38417517
[TBL] [Abstract][Full Text] [Related]
19. Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.
Delcourt N; Claudepierre T; Maignien T; Arnich N; Mattei C
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29271898
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
